News und Analysen
EQS-News: Schaeffler AG: Schaeffler publishes 2022 Sustainability Report
EQS-News: Schaeffler AG: Schaeffler publishes 2022 Sustainability Report
EQS-News: Schaeffler AG: Schaeffler Group closes 2022 with solid earnings
EQS-News: Schaeffler AG: Schaeffler Group closes 2022 with solid earnings
EQS-News: SHOP APOTHEKE EUROPE 2022: RECORD SALES OF EUR 1.2 BILLION AND SIGNIFICANTLY IMPROVED MARGINS IN THE SECOND HALF OF THE YEAR.
EQS-News: SHOP APOTHEKE EUROPE 2022: RECORD SALES OF EUR 1.2 BILLION AND SIGNIFICANTLY IMPROVED MARGINS IN THE SECOND HALF OF THE YEAR.
EQS-News: CEO Stefan Feltens to Retire from SHOP APOTHEKE EUROPE.
EQS-News: CEO Stefan Feltens to Retire from SHOP APOTHEKE EUROPE.
EQS-Adhoc: SHOP APOTHEKE EUROPE N.V.: No prolongation of his term as CEO by Stefan Feltens
EQS-Adhoc: SHOP APOTHEKE EUROPE N.V.: No prolongation of his term as CEO by Stefan Feltens
EQS-News: Schaeffler AG: Acquisition of ECO-Adapt SAS strengthens Schaeffler’s portfolio of Lifetime Solutions
EQS-News: Schaeffler AG: Acquisition of ECO-Adapt SAS strengthens Schaeffler’s portfolio of Lifetime Solutions
EQS-News: Nagarro estimates 2022 revenue grew 48.0% over 2021 in constant currency, reiterates 2023 guidance
EQS-News: Nagarro estimates 2022 revenue grew 48.0% over 2021 in constant currency, reiterates 2023 guidance
EQS-News: GRENKE invests in expanding digitalisation, presents preliminary results for 2022 financial year and publishes outlook for 2023
EQS-News: GRENKE invests in expanding digitalisation, presents preliminary results for 2022 financial year and publishes outlook for 2023
EQS-Adhoc: GRENKE invests in expanding digitalisation, presents preliminary results for 2022 financial year and publishes outlook for 2023
EQS-Adhoc: GRENKE invests in expanding digitalisation, presents preliminary results for 2022 financial year and publishes outlook for 2023
EQS-News: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs
EQS-News: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs
EQS-Adhoc: Ad hoc: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs and Reduces Workforce at its Germany Headquarters
EQS-Adhoc: Ad hoc: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs and Reduces Workforce at its Germany Headquarters
EQS-News: Nagarro SE expands footprint and SAP capabilities with acquisition of MBIS
EQS-News: Nagarro SE expands footprint and SAP capabilities with acquisition of MBIS
EQS-News: 1&1 requests the Federal Cartel Office [Bundeskartellamt] to review the hindrance of the construction of the fourth German mobile network. Slight delays in network launch possible.
EQS-News: 1&1 requests the Federal Cartel Office [Bundeskartellamt] to review the hindrance of the construction of the fourth German mobile network. Slight delays in network launch possible.
EQS-Adhoc: Fielmann AG: Preliminary Figures for FY2022/Dividend
EQS-Adhoc: Fielmann AG: Preliminary Figures for FY2022/Dividend
EQS-News: AUTO1 Group SE: AUTO1 Group reports record results in 2022
EQS-News: AUTO1 Group SE: AUTO1 Group reports record results in 2022
EQS-News: Krones AG: Krones verbesserte 2022 alle wesentlichen Finanzkennzahlen und prognostiziert für 2023 weiteres Umsatz- und Ergebniswachstum
EQS-News: Krones AG: Krones verbesserte 2022 alle wesentlichen Finanzkennzahlen und prognostiziert für 2023 weiteres Umsatz- und Ergebniswachstum
EQS-News: GRENKE: Dr Sebastian Hirsch takes over from Michael Bücker as CEO
EQS-News: GRENKE: Dr Sebastian Hirsch takes over from Michael Bücker as CEO
EQS-Adhoc: GRENKE: Dr Sebastian Hirsch takes over from Michael Bücker as CEO
EQS-Adhoc: GRENKE: Dr Sebastian Hirsch takes over from Michael Bücker as CEO
EQS-News: CANCOM: Second half-year brings 7.5 percent revenue growth. Executive Board announces programme to increase profitability.
EQS-News: CANCOM: Second half-year brings 7.5 percent revenue growth. Executive Board announces programme to increase profitability.
EQS-Adhoc: CANCOM SE: Revenue, ARR and gross profit reach target corridors for 2022. EBITDA and EBITA lower than forecast due to one-off special effects.
EQS-Adhoc: CANCOM SE: Revenue, ARR and gross profit reach target corridors for 2022. EBITDA and EBITA lower than forecast due to one-off special effects.
EQS-News: AUTO1 Group SE: AUTO1 Group extends availability period of inventory financing and increases size of consumer loan refinancing
EQS-News: AUTO1 Group SE: AUTO1 Group extends availability period of inventory financing and increases size of consumer loan refinancing
EQS-News: AUTO1 Group SE: Autohero secures in-house production capacity of up to 4,100 cars in the Netherlands
EQS-News: AUTO1 Group SE: Autohero secures in-house production capacity of up to 4,100 cars in the Netherlands
EQS-News: AUTO1 Group SE: Autohero secures in-house production capacity of up to 4,100 cars in the Netherlands
EQS-News: AUTO1 Group SE: Autohero secures in-house production capacity of up to 4,100 cars in the Netherlands
EQS-News: PATRIZIA and Mitsui launch new flagship strategy for sustainable infrastructure investments in APAC
EQS-News: PATRIZIA and Mitsui launch new flagship strategy for sustainable infrastructure investments in APAC
EQS-News: Schaeffler AG: Climate targets validated by Science Based Targets initiative
EQS-News: Schaeffler AG: Climate targets validated by Science Based Targets initiative